These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 9659870

  • 21. [Eye tracking disorders in schizophrenic patients and their parents].
    Boudet C, Denise P, Bocca ML, Chabot B, Abadie P, Brazo P, Benali K, Dollfus S.
    Encephale; 2001; 27(6):551-8. PubMed ID: 11865562
    [Abstract] [Full Text] [Related]

  • 22. Eye tracking dysfunction in schizophrenia: characterization and pathophysiology.
    Levy DL, Sereno AB, Gooding DC, O'Driscoll GA.
    Curr Top Behav Neurosci; 2010; 4():311-47. PubMed ID: 21312405
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Smooth-pursuit eye movement dysfunction in schizophrenia: the role of attention and general psychomotor dysfunctions.
    Schlenker R, Cohen R, Berg P, Hubman W, Mohr F, Watzl H, Werther P.
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(3):153-60. PubMed ID: 7803530
    [Abstract] [Full Text] [Related]

  • 27. Eye movements in spectrum personality disorders: comparison of community subjects and relatives of schizophrenic patients.
    Thaker GK, Cassady S, Adami H, Moran M, Ross DE.
    Am J Psychiatry; 1996 Mar; 153(3):362-8. PubMed ID: 8610823
    [Abstract] [Full Text] [Related]

  • 28. Obstetric complications in siblings of Japanese schizophrenics: data from the Maternal and Child Health Handbook.
    Ohara K, Tanabu S, Yoshida K, Sato Y, Shibuya H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):617-20. PubMed ID: 15866366
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia.
    Avila MT, Weiler MA, Lahti AC, Tamminga CA, Thaker GK.
    Am J Psychiatry; 2002 Sep; 159(9):1490-6. PubMed ID: 12202268
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Eye tracking performance and the boundaries of the schizophrenia spectrum.
    Mitropoulou V, Friedman L, Zegarelli G, Wajnberg S, Meshberg J, Silverman JM, Siever LJ.
    Psychiatry Res; 2011 Mar 30; 186(1):18-22. PubMed ID: 20826004
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects.
    Rybakowski JK, Borkowska A, Czerski PM, Hauser J.
    Mol Psychiatry; 2001 Nov 30; 6(6):718-24. PubMed ID: 11673801
    [Abstract] [Full Text] [Related]

  • 37. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort.
    Jones PB, Rantakallio P, Hartikainen AL, Isohanni M, Sipila P.
    Am J Psychiatry; 1998 Mar 30; 155(3):355-64. PubMed ID: 9501745
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.